Participant flow16

How many started, completed or left each group, period by period.

1 to 16 of 16

Period	Milestone	Group	Participants
Overall Study	STARTED	Clobazam Low Dose	58
Overall Study	STARTED	Clobazam Medium Dose	62
Overall Study	STARTED	Clobazam High Dose	59
Overall Study	STARTED	Placebo	59
Overall Study	Modified Intent-to-Treat Population	Clobazam Low Dose	53
Overall Study	Modified Intent-to-Treat Population	Clobazam Medium Dose	58
Overall Study	Modified Intent-to-Treat Population	Clobazam High Dose	49
Overall Study	Modified Intent-to-Treat Population	Placebo	57
Overall Study	COMPLETED	Clobazam Low Dose	50
Overall Study	COMPLETED	Clobazam Medium Dose	45
Overall Study	COMPLETED	Clobazam High Dose	41
Overall Study	COMPLETED	Placebo	41
Overall Study	NOT COMPLETED	Clobazam Low Dose	8
Overall Study	NOT COMPLETED	Clobazam Medium Dose	17
Overall Study	NOT COMPLETED	Clobazam High Dose	18
Overall Study	NOT COMPLETED	Placebo	18

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00518713/flow